DZ3159A1 - Derives de purine. - Google Patents

Derives de purine.

Info

Publication number: DZ3159A1
Authority: DZ; Algeria
Prior art keywords: purine derivatives; purine; derivatives
Prior art date: 1999-10-14

Application number

DZ003159A

Other languages

English (en)

French (fr)

Inventor

Sandra Marina Monaghan

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-10-14

Filing date

2000-10-06

Publication date

2001-04-19

2000-10-06 Application filed by Pfizer filed Critical Pfizer

2001-04-19 Application granted granted Critical

2001-04-19 Publication of DZ3159A1 publication Critical patent/DZ3159A1/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/167—Purine radicals with ribosyl as the saccharide radical

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pulmonology (AREA)
Genetics & Genomics (AREA)
Neurosurgery (AREA)
Heart & Thoracic Surgery (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Diabetes (AREA)
Biotechnology (AREA)
Cardiology (AREA)
Neurology (AREA)
Biochemistry (AREA)
Endocrinology (AREA)
Dermatology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Immunology (AREA)
Hematology (AREA)
Psychiatry (AREA)
Oncology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Communicable Diseases (AREA)
Gynecology & Obstetrics (AREA)
Reproductive Health (AREA)
Otolaryngology (AREA)

DZ003159A 1999-10-14 2000-10-06 Derives de purine. DZ3159A1 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9924363.6A GB9924363D0 (en)	1999-10-14	1999-10-14	Purine derivatives
IB0011444		2000-10-06

Publications (1)

Publication Number	Publication Date
DZ3159A1 true DZ3159A1 (fr)	2001-04-19

Family

ID=10862760

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DZ003159A DZ3159A1 (fr)	1999-10-14	2000-10-06	Derives de purine.

Country Status (50)

Country	Link
US (1)	US6350735B1 (is)
EP (1)	EP1220863B1 (is)
JP (1)	JP3994007B2 (is)
KR (1)	KR20020037774A (is)
CN (1)	CN1151167C (is)
AP (1)	AP1442A (is)
AR (1)	AR023275A1 (is)
AT (1)	ATE238336T1 (is)
AU (1)	AU768308B2 (is)
BG (1)	BG106569A (is)
BR (1)	BR0011776A (is)
CA (1)	CA2387531C (is)
CO (1)	CO5251399A1 (is)
CR (1)	CR6584A (is)
CZ (1)	CZ20021223A3 (is)
DE (1)	DE60002356T2 (is)
DK (1)	DK1220863T3 (is)
DZ (1)	DZ3159A1 (is)
EA (1)	EA004655B1 (is)
EC (1)	ECSP003712A (is)
EE (1)	EE200200193A (is)
ES (1)	ES2193990T3 (is)
GB (1)	GB9924363D0 (is)
GE (1)	GEP20043269B (is)
GT (1)	GT200000172A (is)
HK (1)	HK1047110B (is)
HN (1)	HN2000000204A (is)
HU (1)	HUP0203483A2 (is)
IL (1)	IL146342A0 (is)
IS (1)	IS6165A (is)
MA (1)	MA26828A1 (is)
MX (1)	MXPA02003812A (is)
MY (1)	MY136242A (is)
NO (1)	NO20021692L (is)
NZ (1)	NZ515323A (is)
OA (1)	OA12059A (is)
PA (1)	PA8503501A1 (is)
PE (1)	PE20010755A1 (is)
PL (1)	PL354932A1 (is)
PT (1)	PT1220863E (is)
SI (1)	SI1220863T1 (is)
SK (1)	SK4842002A3 (is)
SV (1)	SV2002000198A (is)
TN (1)	TNSN00202A1 (is)
TR (1)	TR200200985T2 (is)
UA (1)	UA66945C2 (is)
UY (1)	UY26397A1 (is)
WO (1)	WO2001027130A1 (is)
YU (1)	YU88901A (is)
ZA (1)	ZA200202849B (is)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7427606B2 (en) *	1999-02-01	2008-09-23	University Of Virginia Patent Foundation	Method to reduce inflammatory response in transplanted tissue
US7378400B2 (en) *	1999-02-01	2008-05-27	University Of Virginia Patent Foundation	Method to reduce an inflammatory response from arthritis
GB0003960D0 (en)	2000-02-18	2000-04-12	Pfizer Ltd	Purine derivatives
GB0015727D0 (en) *	2000-06-27	2000-08-16	Pfizer Ltd	Purine derivatives
US6921753B2 (en)	2000-06-27	2005-07-26	Pfizer Inc	Purine derivatives
GB0022695D0 (en)	2000-09-15	2000-11-01	Pfizer Ltd	Purine Derivatives
AP2003002911A0 (en) *	2001-05-25	2003-12-31	Pfizer	An adenosine A2A receptor agonist and an anticholinergic agent in combination for treating obstructive airways diseases.
EP1434782A2 (en) *	2001-10-01	2004-07-07	University of Virginia Patent Foundation	2-propynyl adenosine analogs having a2a agonist activity and compositions thereof
ATE381336T1 (de) *	2002-04-10	2008-01-15	Univ Virginia	Verwendung von a2a adenosin rezeptor agonisten und anti-pathogene mittel enthaltenden kombinationen zur behandlung von entzündungskrankheiten
TW200519106A (en)	2003-05-02	2005-06-16	Novartis Ag	Organic compounds
US20050033044A1 (en)	2003-05-19	2005-02-10	Bristol-Myers Squibb Pharma Company	Methods for preparing 2-alkynyladenosine derivatives
GB0401334D0 (en)	2004-01-21	2004-02-25	Novartis Ag	Organic compounds
GB0411056D0 (en)	2004-05-18	2004-06-23	Novartis Ag	Organic compounds
EP2266994B1 (en) *	2004-08-02	2013-04-03	University Of Virginia Patent Foundation	2-propynyl adenosine analgos with modified 5'-ribose groups having A2A agonist activity
WO2006023272A1 (en) *	2004-08-02	2006-03-02	University Of Virginia Patent Foundation	2-polycyclic propynyl adenosine analogs having a2a agonist activity
US7576069B2 (en) *	2004-08-02	2009-08-18	University Of Virginia Patent Foundation	2-polycyclic propynyl adenosine analogs having A2A agonist activity
GB0424284D0 (en)	2004-11-02	2004-12-01	Novartis Ag	Organic compounds
GB0426164D0 (en)	2004-11-29	2004-12-29	Novartis Ag	Organic compounds
GB0510390D0 (en)	2005-05-20	2005-06-29	Novartis Ag	Organic compounds
EP1893593A1 (en) *	2005-06-15	2008-03-05	Pfizer Limited	3-phenylazetidine derivatives as dopamine agonists
CN100352823C (zh) *	2005-08-19	2007-12-05	浙江车头制药有限公司	一种腺嘌呤衍生物的制备方法
KR20080049113A (ko)	2005-10-21	2008-06-03	노파르티스 아게	Ｉｌ-13에 대항한 인간 항체 및 치료적 용도
GB0601951D0 (en)	2006-01-31	2006-03-15	Novartis Ag	Organic compounds
US20080027022A1 (en) *	2006-02-08	2008-01-31	Linden Joel M	Method to treat gastric lesions
US8178509B2 (en)	2006-02-10	2012-05-15	University Of Virginia Patent Foundation	Method to treat sickle cell disease
US8188063B2 (en) *	2006-06-19	2012-05-29	University Of Virginia Patent Foundation	Use of adenosine A2A modulators to treat spinal cord injury
US20090286779A1 (en)	2006-09-29	2009-11-19	Novartis Ag	Pyrazolopyrimidines as lipid kinase inhibitors
EP2089393A1 (en)	2006-10-30	2009-08-19	Novartis AG	Heterocyclic compounds as antiinflammatory agents
US8058259B2 (en) *	2007-12-20	2011-11-15	University Of Virginia Patent Foundation	Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists
US8431578B2 (en)	2008-01-11	2013-04-30	Novartis Ag	Organic compounds
SI2391366T1 (sl)	2009-01-29	2013-01-31	Novartis Ag	Substituirani benzimidazoli za zdravljenje astrocitomov
US8389526B2 (en)	2009-08-07	2013-03-05	Novartis Ag	3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives
US8497368B2 (en)	2009-08-12	2013-07-30	Novartis Ag	Heterocyclic hydrazone compounds
ES2709108T3 (es)	2009-08-17	2019-04-15	Intellikine Llc	Compuestos heterocíclicos y usos de los mismos
EA201200318A1 (ru)	2009-08-20	2012-09-28	Новартис Аг	Гетероциклические оксимы
WO2012034095A1 (en)	2010-09-09	2012-03-15	Irm Llc	Compounds and compositions as trk inhibitors
US8637516B2 (en)	2010-09-09	2014-01-28	Irm Llc	Compounds and compositions as TRK inhibitors
US20130324526A1 (en)	2011-02-10	2013-12-05	Novartis Ag	[1,2,4] triazolo [4,3-b] pyridazine compounds as inhibitors of the c-met tyrosine kinase
WO2012116237A2 (en)	2011-02-23	2012-08-30	Intellikine, Llc	Heterocyclic compounds and uses thereof
JP5959541B2 (ja)	2011-02-25	2016-08-02	ノバルティスアーゲー	Ｔｒｋ阻害剤としてのピラゾロ［１，５−ａ］ピリジン
EA026655B1 (ru)	2011-09-15	2017-05-31	Новартис Аг	6-ЗАМЕЩЕННЫЕ 3-(ХИНОЛИН-6-ИЛТИО)[1,2,4]ТРИАЗОЛО[4,3-a]ПИРИДИНЫ В КАЧЕСТВЕ ИНГИБИТОРОВ c-MET ТИРОЗИНКИНАЗЫ
EP2793893A4 (en)	2011-11-23	2015-07-08	Intellikine Llc	IMPROVED TREATMENT REGIMES USING MTOR INHIBITORS
EP3964513A1 (en)	2012-04-03	2022-03-09	Novartis AG	Combination products with tyrosine kinase inhibitors and their use
JP2016512835A (ja)	2013-03-15	2016-05-09	インテリカイン，エルエルシー	キナーゼ阻害剤の組み合わせ及びそれらの使用
WO2015084804A1 (en)	2013-12-03	2015-06-11	Novartis Ag	Combination of mdm2 inhibitor and braf inhibitor and their use
WO2016011658A1 (en)	2014-07-25	2016-01-28	Novartis Ag	Combination therapy
US10195208B2 (en)	2014-07-31	2019-02-05	Novartis Ag	Combination therapy
TW202140550A (zh)	2020-01-29	2021-11-01	瑞士商諾華公司	使用抗ｔｓｌｐ抗體治療炎性或阻塞性氣道疾病之方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5536419A (en) *	1978-09-08	1980-03-14	Yamasa Shoyu Co Ltd	2-substituted adenosine derivative and its preparation
AU8276187A (en) *	1986-10-31	1988-05-25	Warner-Lambert Company	Selected n6-substituted adenosines having selective a2 binding activity
US5376645A (en)	1990-01-23	1994-12-27	University Of Kansas	Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
KR0166088B1 (ko)	1990-01-23	1999-01-15	.	수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
US5877180A (en) *	1994-07-11	1999-03-02	University Of Virginia Patent Foundation	Method for treating inflammatory diseases with A2a adenosine receptor agonists
GB9711643D0 (en)	1997-06-05	1997-07-30	Janssen Pharmaceutica Nv	Glass thermoplastic systems
ATE331726T1 (de) *	1998-10-16	2006-07-15	Pfizer	Adenine-derivate

1999
- 1999-10-14 GB GBGB9924363.6A patent/GB9924363D0/en not_active Ceased
2000
- 2000-09-14 HN HN2000000204A patent/HN2000000204A/es unknown
- 2000-09-26 PA PA20008503501A patent/PA8503501A1/es unknown
- 2000-10-06 MX MXPA02003812A patent/MXPA02003812A/es active IP Right Grant
- 2000-10-06 DK DK00964566T patent/DK1220863T3/da active
- 2000-10-06 SK SK484-2002A patent/SK4842002A3/sk unknown
- 2000-10-06 AP APAP/P/2002/002478A patent/AP1442A/en active
- 2000-10-06 TR TR2002/00985T patent/TR200200985T2/xx unknown
- 2000-10-06 PL PL00354932A patent/PL354932A1/xx not_active Application Discontinuation
- 2000-10-06 EE EEP200200193A patent/EE200200193A/xx unknown
- 2000-10-06 CN CNB008096287A patent/CN1151167C/zh not_active Expired - Fee Related
- 2000-10-06 PT PT00964566T patent/PT1220863E/pt unknown
- 2000-10-06 HU HU0203483A patent/HUP0203483A2/hu unknown
- 2000-10-06 SI SI200030102T patent/SI1220863T1/xx unknown
- 2000-10-06 ES ES00964566T patent/ES2193990T3/es not_active Expired - Lifetime
- 2000-10-06 EA EA200101107A patent/EA004655B1/ru not_active IP Right Cessation
- 2000-10-06 BR BR0011776-5A patent/BR0011776A/pt not_active IP Right Cessation
- 2000-10-06 DE DE60002356T patent/DE60002356T2/de not_active Expired - Fee Related
- 2000-10-06 EP EP00964566A patent/EP1220863B1/en not_active Expired - Lifetime
- 2000-10-06 CA CA002387531A patent/CA2387531C/en not_active Expired - Fee Related
- 2000-10-06 CZ CZ20021223A patent/CZ20021223A3/cs unknown
- 2000-10-06 OA OA1200200102A patent/OA12059A/en unknown
- 2000-10-06 JP JP2001530348A patent/JP3994007B2/ja not_active Expired - Fee Related
- 2000-10-06 KR KR1020027004748A patent/KR20020037774A/ko active IP Right Grant
- 2000-10-06 NZ NZ515323A patent/NZ515323A/en unknown
- 2000-10-06 WO PCT/IB2000/001444 patent/WO2001027130A1/en active IP Right Grant
- 2000-10-06 YU YU88901A patent/YU88901A/sh unknown
- 2000-10-06 DZ DZ003159A patent/DZ3159A1/xx active
- 2000-10-06 IL IL14634200A patent/IL146342A0/xx unknown
- 2000-10-06 GE GEAP20006243A patent/GEP20043269B/en unknown
- 2000-10-06 AU AU75488/00A patent/AU768308B2/en not_active Ceased
- 2000-10-06 AT AT00964566T patent/ATE238336T1/de not_active IP Right Cessation
- 2000-10-06 UA UA2002042943A patent/UA66945C2/uk unknown
- 2000-10-12 MY MYPI20004790A patent/MY136242A/en unknown
- 2000-10-12 EC EC2000003712A patent/ECSP003712A/es unknown
- 2000-10-12 GT GT200000172A patent/GT200000172A/es unknown
- 2000-10-12 CO CO00077985A patent/CO5251399A1/es not_active Application Discontinuation
- 2000-10-13 TN TNTNSN00202A patent/TNSN00202A1/fr unknown
- 2000-10-13 AR ARP000105421A patent/AR023275A1/es unknown
- 2000-10-13 PE PE2000001098A patent/PE20010755A1/es not_active Application Discontinuation
- 2000-10-13 UY UY26397A patent/UY26397A1/es not_active Application Discontinuation
- 2000-10-13 SV SV2000000198A patent/SV2002000198A/es unknown
- 2000-10-16 US US09/688,624 patent/US6350735B1/en not_active Expired - Fee Related
2001
- 2001-11-16 IS IS6165A patent/IS6165A/is unknown
2002
- 2002-02-08 CR CR6584A patent/CR6584A/es not_active Application Discontinuation
- 2002-04-02 BG BG106569A patent/BG106569A/xx unknown
- 2002-04-09 MA MA26590A patent/MA26828A1/fr unknown
- 2002-04-10 NO NO20021692A patent/NO20021692L/no not_active Application Discontinuation
- 2002-04-11 ZA ZA200202849A patent/ZA200202849B/xx unknown
- 2002-11-29 HK HK02108605.8A patent/HK1047110B/zh not_active IP Right Cessation

Also Published As

Publication number	Publication date
PL354932A1 (en)	2004-03-22
ES2193990T3 (es)	2003-11-16
EE200200193A (et)	2003-06-16
IL146342A0 (en)	2002-07-25
IS6165A (is)	2001-11-16
DK1220863T3 (da)	2003-08-11
MY136242A (en)	2008-08-29
HK1047110B (zh)	2005-03-04
AR023275A1 (es)	2002-09-04
UY26397A1 (es)	2001-05-31
JP2003511459A (ja)	2003-03-25
SI1220863T1 (en)	2003-10-31
GT200000172A (es)	2002-04-05
HUP0203483A2 (hu)	2003-02-28
HN2000000204A (es)	2001-06-21
BR0011776A (pt)	2002-03-12
CO5251399A1 (es)	2003-02-28
CA2387531C (en)	2006-12-05
UA66945C2 (uk)	2004-06-15
SV2002000198A (es)	2002-02-05
PT1220863E (pt)	2003-07-31
KR20020037774A (ko)	2002-05-22
OA12059A (en)	2006-05-03
ZA200202849B (en)	2003-06-25
CZ20021223A3 (cs)	2003-05-14
NO20021692D0 (no)	2002-04-10
SK4842002A3 (en)	2003-06-03
MA26828A1 (fr)	2004-12-20
CR6584A (es)	2004-01-14
DE60002356D1 (de)	2003-05-28
GEP20043269B (en)	2004-06-25
JP3994007B2 (ja)	2007-10-17
AU768308B2 (en)	2003-12-04
US6350735B1 (en)	2002-02-26
TNSN00202A1 (fr)	2005-11-10
AP2002002478A0 (en)	2002-06-30
PA8503501A1 (es)	2002-02-21
MXPA02003812A (es)	2002-09-30
ATE238336T1 (de)	2003-05-15
AP1442A (en)	2005-06-29
WO2001027130A1 (en)	2001-04-19
EA200101107A1 (ru)	2002-10-31
EA004655B1 (ru)	2004-06-24
DE60002356T2 (de)	2004-02-19
BG106569A (en)	2002-12-29
CA2387531A1 (en)	2001-04-19
GB9924363D0 (en)	1999-12-15
CN1358192A (zh)	2002-07-10
NO20021692L (no)	2002-04-10
TR200200985T2 (tr)	2002-10-21
CN1151167C (zh)	2004-05-26
HK1047110A1 (en)	2003-02-07
PE20010755A1 (es)	2001-07-17
AU7548800A (en)	2001-04-23
EP1220863B1 (en)	2003-04-23
ECSP003712A (es)	2002-05-23
NZ515323A (en)	2003-10-31
EP1220863A1 (en)	2002-07-10
YU88901A (sh)	2004-09-03

Publication	Publication Date	Title
DZ3159A1 (fr)	2001-04-19	Derives de purine.
MA26799A1 (fr)	2004-12-20	Derives de purine
MA26832A1 (fr)	2004-12-20	Derives de benzodiazepine.
ATE321065T1 (de)	2006-04-15	Purin-derivate
MA26918A1 (fr)	2004-12-20	Derives de purine
TR200000520A3 (tr)	2001-06-21	4-Fenil-piridin türevleri.
DZ3439A1 (fr)	2001-12-13	Derives de 2-aminocarbonyl-9h-purine
MA26794A1 (fr)	2004-12-20	Derives de 5-phenyl-pyrimidine.
NO20010743D0 (no)	2001-02-14	Antivirale indoloksoacetyl-piperazin-derivater
DE60119492D1 (de)	2006-06-14	Purinderivate
FR2810318B1 (fr)	2005-09-23	Derives de diamano-phenothiazine
PT1154988E (pt)	2004-12-31	Derivados de mevinolina
MA26793A1 (fr)	2004-12-20	Derives de 4-phenyl-pyrimidine.
MA26967A1 (fr)	2004-12-20	Derives de pyrimidine
PT1088818E (pt)	2005-03-31	Derivados de quinolin-4-ilo
PT1194401E (pt)	2004-02-27	Derivados de diacil-hidrazina
DK1090019T3 (da)	2005-02-07	Adenosinderivater
ES1044710Y (es)	2000-10-16	Cenicero perfeccionado.
TH109999B (th)	2011-08-16	นิวคลีโอไซด์